This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Innopsys, Inc. for an extended warranty maintenance contract. The $9,894 award does not have a set-aside designation and has a period of performance from March 11, 2025 to March 11, 2025. Innopsys, Inc. is a private company that develops and sells fluorescence confocal scanners and image analysis software for biomedical research and public health applications. Through prior federal contracts, Innopsys has provided biomedical equipment, including InnoScan fluorescence scanners, to support COVID-19 research initiatives and other programs at the Department of Health and Human Services, including the CDC, National Institutes of Health, and National Cancer Institute.
Generated 3/12/25, 9:42 AM